INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Inogen Inc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$6.55+0.30 (+4.80%)

Close on Oct 19, 2026

Market cap: $177.15M
P/E (TTM): –
Dividend yield: –

Inogen Inc income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31
Revenue	349	336	316	377	358	308	362	358	249	203	159	113	75	49
Cost of Revenue	194	181	189	224	182	170	190	180	128	106	83	57	36	25
Gross Profit	154	155	127	154	176	138	172	179	121	97	76	56	39	24
Research & Development	19	22	21	22	17	14	9.40	7.03	5.31	5.11	4.18	2.98	2.40	2.26
Selling, General & Admin	165	176	182	165	151	136	143	134	88	69	57	42	32	21
Selling & Marketing	98	103	107	121	113	98	106	96	51	38	31	24	18	13
General & Administrative	67	73	75	44	38	39	37	38	38	32	26	18	14	8.29
Advertising Expenses	29	32	27	33	35	34	40	31	13	6.22	4.69	3.29	2.84	2.50
Operating Expenses	184	197	236	239	167	150	152	141	94	74	61	45	35	23
Operating Income	-30	-43	-109	-85	9.24	-12	20	38	28	23	15	11	4.46	0.83
Interest Expense	–	–	–	–	–	–	–	–	–	0.01	0.02	0.45	0.56	0.49
Interest & Investment Income	4.39	5.19	6.57	2.84	0.13	0.91	4.71	3.26	0.77	0.20	0.10	0.04	0.01	0.09
Other Non-Operating Income	6.83	6.04	7.04	1.98	-0.58	6.75	4.48	2.56	2.07	-0.14	-0.32	-0.46	-0.62	-0.25
Merger & Restructuring Charges	0	0	3.43	–	–	–	–	–	–	–	–	–	–	–
Asset Impairment Charges	0	0	33	0	0	0	0	0	0	0	0	0	0	–
Gain (Loss) on Sale of Assets	-0.06	0.17	0.08	0.15	0.07	0.09	0.07	0.42	0.06	0.27	–	-1.90	-0.31	-0.26
Pretax Income	-23	-36	-102	-83	8.66	-5.28	24	40	30	23	15	10	3.85	0.58
Income Tax Expense	-0.63	-0.59	0.11	0.50	15	0.55	3.32	-11	8.65	2.21	3.14	3.23	-22	0.02
Net Income	-23	-36	-102	-84	-6.33	-5.83	21	52	21	21	12	6.83	25	0.56
Preferred Dividends	–	–	–	–	–	–	–	–	–	–	–	–	7.17	–
Net Income to Common	–	–	–	–	–	–	–	–	–	21	12	5.33	1.37	-5.22
EPS (Basic)(per share)	-0.86	-1.52	-4.42	-3.67	-0.28	-0.27	0.96	2.44	1.02	1.02	0.60	0.33	0.76	-19.97
EPS (Diluted)(per share)	-0.86	-1.52	-4.42	-3.67	-0.28	-0.27	0.94	2.30	0.96	0.97	0.56	0.30	0.68	-19.97
Shares Outstanding (Basic, Weighted)(shares)	27	24	23	23	22	22	22	21	21	20	19	16	0.28	0.26
Shares Outstanding (Diluted, Weighted)(shares)	27	24	23	23	22	22	22	23	22	21	21	18	2.01	0.26
EBITDA	-9.55	-22	-91	-62	31	6.56	34	49	40	36	29	23	13	5.81

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 44.5%
Operating margin: -8.7%
Net margin: -6.9%
Return on equity, FY2025: -12.4%

Financial strength

Current ratio: 2.74
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 123.2%

Valuation

P/E ratio: –
Price to sales: 0.50
Price to book: 1.01
Dividend yield: –